apomorphine hydrocloride
- Product NDC
- 52817-720
- 11-digit product format
- 528170720
- Labeler code
- 52817
- Product ID
- 52817-720_2fbd7414-f94f-4e18-8d0e-3ae69a5449f7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- APOMORPHINE HYDROCHLORIDE
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- TruPharma, LLC
- Application
- ANDA212025
- Marketing category
- ANDA
- Marketing start
- 2022-02-24
- Substance
- APOMORPHINE HYDROCHLORIDE
- Active strength
- 30 mg/3mL
- Pharmacologic classes
- Dopamine Agonists [MoA], Dopaminergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212025-001 | APOMORPHINE HYDROCHLORIDE | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212025-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 4b0b4de00fa7… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212025-001 | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2022-02-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A212025-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212025-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A212025-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212025-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212025-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212025-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212025-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212025-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212025-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A212025-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212025-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212025-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212025-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A212025-001 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212025-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A212025-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A212025-001 | AP | 1 | 4b0b4de00fa7… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A212025-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A212025-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A212025-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A212025-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A212025-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A212025-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A212025-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A212025-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A212025-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A212025-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A212025-001 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A212025-001 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A212025-001 | AP | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212025-001 | AP | 1 | a50c72e98297… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212025-001 | CGT | 2022-08-24 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A212025-001 | CGT | 2022-08-24 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A212025-001 | CGT | 2022-08-24 | 4b0b4de00fa7… |
| 2023-01-26 05:58 UTC | 2023-01 | A212025-001 | CGT | 2022-08-24 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A212025-001 | CGT | 2022-08-24 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A212025-001 | CGT | 2022-08-24 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A212025-001 | CGT | 2022-08-24 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A212025-001 | CGT | 2022-08-24 | cb3db0bc1861… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- apomorphine hydrocloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| APOMORPHINE HYDROCHLORIDE | 30 mg/3mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| F39049Y068 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 855856 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| aedf70e4-1949-44bc-bf1b-0f282c4f0705 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 8cacec2b-1363-4e94-885c-4189d5e7208a | Product name | 1 | 20251117 |
| d7fea1a2-3459-27e8-1231-1b79988f4937 | Product name | 2 | 20221207 |
| 3a53909e-cbfb-4956-984e-a33101906fd9 | Product name | 1 | 20201021 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52817-720-01 | apomorphine hydrocloride | 3 mL in 1 CARTRIDGE | INJECTION | 3 | 1 | |
| 52817-720-05 | apomorphine hydrocloride | 5 in 1 CARTON | INJECTION | 5 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 52817-720-01 | ML - Milliliter | 52817-720 | d44b4ba3-5faf-4db9-97e2-8889ef8b37dc | 1 | 2022-03-09 |
| 52817-720-05 | ML - Milliliter | 52817-720 | c4ace5b2-bf2d-498c-bfbd-1ed7d02a32b2 | 1 | 2022-03-09 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| apomorphine hydrocloride | APOMORPHINE HYDROCHLORIDE | TruPharma, LLC | aedf70e4-1949-44bc-bf1b-0f282c4f0705 | 2022-02-24 | Warnings, Adverse reactions | 212025 ANDA212025 52817-720 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 855856 | apomorphine HCl 30 MG in 3 mL Cartridge | PSN | aedf70e4-1949-44bc-bf1b-0f282c4f0705 | 1 |
| 855856 | 3 ML apomorphine hydrochloride 10 MG/ML Cartridge | SCD | aedf70e4-1949-44bc-bf1b-0f282c4f0705 | 1 |
| 855856 | apomorphine HCl 30 MG per 3 ML Cartridge | SY | aedf70e4-1949-44bc-bf1b-0f282c4f0705 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 52817-720-01 | 52817072001 | 3 mL in 1 CARTRIDGE | 3 ml | Historical | ||||
| 52817-720-05 | 52817072005 | 5 CARTRIDGE in 1 CARTON (52817-720-05) / 3 mL in 1 CARTRIDGE (52817-720-01) | 5 cartridge | 2022-02-24 | 0000-00-00 | No | No | Current |